Literature DB >> 25404017

Cardiovascular endocrinology: Growth hormone in CVD prediction--a tall order?

Connie W Tsao1, Ramachandran S Vasan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25404017     DOI： 10.1038/nrendo.2014.204

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.

Authors:  B Bülow; L Hagmar; J Eskilsson; E M Erfurth
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

2.  Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

Authors:  Roger Abs; Ulla Feldt-Rasmussen; Anders F Mattsson; John P Monson; Bengt-Ake Bengtsson; Miklós I Góth; Patrick Wilton; Maria Koltowska-Häggström
Journal:  Eur J Endocrinol       Date:  2006-07       Impact factor: 6.664

3.  Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study.

Authors:  P Maison; B Balkau; D Simon; P Chanson; G Rosselin; E Eschwège
Journal:  BMJ       Date:  1998-04-11

4.  Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

Authors:  Karen T Coschigano; Amy N Holland; Markus E Riders; Edward O List; Allan Flyvbjerg; John J Kopchick
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 5.  Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences.

Authors:  Martin Bidlingmaier; Pamela U Freda
Journal:  Growth Horm IGF Res       Date:  2009-10-08       Impact factor: 2.372

6.  An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.

Authors:  Kevin McGeechan; Petra Macaskill; Les Irwig; Patrick Mm Bossuyt
Journal:  BMC Med Res Methodol       Date:  2014-07-03       Impact factor: 4.615

7.  Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review).

Authors:  Ming-Jie Yuan; He Huang; Cong-Xin Huang
Journal:  Oncol Lett       Date:  2014-06-12       Impact factor: 2.967

8.  Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study.

Authors:  Erik Hallengren; Peter Almgren; Gunnar Engström; Bo Hedblad; Margaretha Persson; Jennifer Suhr; Andreas Bergmann; Olle Melander
Journal:  J Am Coll Cardiol       Date:  2014-10-07       Impact factor: 24.094

Review 9.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.